(Q38259507)

1 September 2017

1 reference

title

Novel therapeutics for type 2 diabetes: insulin resistance (English)

1 reference

1 September 2017

0 references

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25308775%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

author name string

Q-A Altaf

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25308775%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

A H Barnett

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25308775%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

publication date

12 November 2014

1 reference

Diabetes, Obesity and Metabolism

1 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25308775%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25308775%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25308775%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

page(s)

319-334

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25308775%20AND%20SRC:MED&resulttype=core&format=json

Global estimates of diabetes prevalence for 2013 and projections for 2035.

5 June 2020

cites work

1 reference

Type 2 diabetes: principles of pathogenesis and therapy

21 January 2018

1 reference

Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus

21 January 2018

1 reference

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

21 January 2018

1 reference

The pathobiology of diabetic complications: a unifying mechanism

21 January 2018

1 reference

Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators.

21 January 2018

1 reference

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

21 January 2018

1 reference

Cellular and molecular mechanisms of endothelial dysfunction in diabetes

21 January 2018

1 reference

Role of insulin resistance in endothelial dysfunction

21 January 2018

1 reference

Insulin resistance and cardiovascular disease

21 January 2018

1 reference

Sympathetic nervous activation in obesity and the metabolic syndrome--causes, consequences and therapeutic implications.

21 January 2018

1 reference

Glycaemic control in type 2 diabetes: targets and new therapies

21 January 2018

1 reference

Treating insulin resistance: future prospects.

21 January 2018

1 reference

Mechanisms linking obesity to insulin resistance and type 2 diabetes

21 January 2018

1 reference

The beta-cell in human type 2 diabetes.

21 January 2018

1 reference

Genetic dissection of type 2 diabetes

21 January 2018

1 reference

The twentieth century struggle to decipher insulin signalling

21 January 2018

1 reference

Mechanisms for insulin resistance: common threads and missing links

21 January 2018

1 reference

Inhibition of HDAC3 as a strategy for developing novel diabetes therapeutics

21 January 2018

1 reference

Intensive lifestyle changes are necessary to improve insulin sensitivity: a randomized controlled trial

21 January 2018

1 reference

Sibutramine improves fat distribution and insulin resistance, and increases serum adiponectin levels in Korean obese nondiabetic premenopausal women.

21 January 2018

1 reference

Effects of moderate weight loss and orlistat on insulin resistance, regional adiposity, and fatty acids in type 2 diabetes

21 January 2018

1 reference

Bariatric surgery versus intensive medical therapy in obese patients with diabetes

21 January 2018

1 reference

Management of type 2 diabetes: new and future developments in treatment

21 January 2018

1 reference

Metformin, heart failure, and lactic acidosis: is metformin absolutely contraindicated?

21 January 2018

1 reference

A novel hydroxyfuroic acid compound as an insulin receptor activator. Structure and activity relationship of a prenylindole moiety to insulin receptor activation

21 January 2018

1 reference

Discovery of a small molecule insulin receptor activator

21 January 2018

1 reference

Non-peptidyl insulin mimetics as a potential antidiabetic agent

21 January 2018

1 reference

Signaling Effects of Demethylasterriquinone B1, a Selective Insulin Receptor Modulator

21 January 2018

1 reference

Activation of insulin signal transduction pathway and anti-diabetic activity of small molecule insulin receptor activators

21 January 2018

1 reference

Diabetes-induced renal vascular dysfunction is normalized by inhibition of epidermal growth factor receptor tyrosine kinase.

21 January 2018

1 reference

A novel small molecule that directly sensitizes the insulin receptor in vitro and in vivo

21 January 2018

1 reference

Effects of vanadium (III, IV, V)-chlorodipicolinate on glycolysis and antioxidant status in the liver of STZ-induced diabetic rats

21 January 2018

1 reference

Effect of vanadium on insulin sensitivity in patients with impaired glucose tolerance.

21 January 2018

1 reference

Insulin-stimulated hydrogen peroxide reversibly inhibits protein-tyrosine phosphatase 1b in vivo and enhances the early insulin action cascade

21 January 2018

1 reference

Recent advances in the discovery of competitive protein tyrosine phosphatase 1B inhibitors for the treatment of diabetes, obesity, and cancer

21 January 2018

1 reference

Reduction of protein tyrosine phosphatase 1B increases insulin-dependent signaling in ob/ob mice

21 January 2018

1 reference

Thiazolidinedione derivatives as PTP1B inhibitors with antihyperglycemic and antiobesity effects

21 January 2018

1 reference

PTP1B and TC-PTP: regulators of transformation and tumorigenesis

21 January 2018

1 reference

Activation of protein kinase C isoforms and its impact on diabetic complications

21 January 2018

1 reference

Protein kinase C inhibition ameliorates functional endothelial insulin resistance and vascular smooth muscle cell hypersensitivity to insulin in diabetic hypertensive rats

21 January 2018

1 reference

Specific inhibition of PTEN expression reverses hyperglycemia in diabetic mice

21 January 2018

1 reference

PTEN mutations as a cause of constitutive insulin sensitivity and obesity.

21 January 2018

1 reference

Potential role and therapeutic interests of myo-inositol in metabolic diseases

21 January 2018

1 reference

Insulin-like effect of pinitol

21 January 2018

1 reference

Effects of D-chiroinositol added to a meal on plasma glucose and insulin in hyperinsulinemic rhesus monkeys.

21 January 2018

1 reference

Molecular cloning of rat SH2-containing inositol phosphatase 2 (SHIP2) and its role in the regulation of insulin signaling

21 January 2018

1 reference

The lipid phosphatase SHIP2 controls insulin sensitivity

21 January 2018

1 reference

SIRT1 metabolic actions: Integrating recent advances from mouse models

21 January 2018

1 reference

Resveratrol, a red wine antioxidant, possesses an insulin-like effect in streptozotocin-induced diabetic rats

21 January 2018

1 reference

Calorie Restriction-like Effects of 30 Days of Resveratrol Supplementation on Energy Metabolism and Metabolic Profile in Obese Humans

21 January 2018

1 reference

Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients.

21 January 2018

1 reference

Grape resveratrol increases serum adiponectin and downregulates inflammatory genes in peripheral blood mononuclear cells: a triple-blind, placebo-controlled, one-year clinical trial in patients with stable coronary artery disease

21 January 2018

1 reference

Pilot study of resveratrol in older adults with impaired glucose tolerance.

21 January 2018

1 reference

Resveratrol supplementation does not improve metabolic function in nonobese women with normal glucose tolerance

21 January 2018

1 reference

High-dose resveratrol supplementation in obese men: an investigator-initiated, randomized, placebo-controlled clinical trial of substrate metabolism, insulin sensitivity, and body composition.

21 January 2018

1 reference

High-dose resveratrol treatment for 2 weeks inhibits intestinal and hepatic lipoprotein production in overweight/obese men.

21 January 2018

1 reference

A novel IKKbeta inhibitor stimulates adiponectin levels and ameliorates obesity-linked insulin resistance

21 January 2018

1 reference

Role of resistin in insulin sensitivity in rodents and humans

21 January 2018

1 reference

Role of leptin and adiponectin in insulin resistance

21 January 2018

1 reference

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

21 January 2018

1 reference

Apelin stimulates glucose utilization in normal and obese insulin-resistant mice

21 January 2018

1 reference

Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy

21 January 2018

1 reference

Apelin and insulin resistance: another arrow for the quiver?

21 January 2018

1 reference

Overexpression of 11beta-hydroxysteroid dehydrogenase-1 in adipose tissue is associated with acquired obesity and features of insulin resistance: studies in young adult monozygotic twins

21 January 2018

1 reference

Cortisol metabolism and the role of 11beta-hydroxysteroid dehydrogenase

21 January 2018

1 reference

Local and systemic impact of transcriptional up-regulation of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue in human obesity

21 January 2018

1 reference

11beta-hydroxysteroid dehydrogenase type 1 regulates glucocorticoid-induced insulin resistance in skeletal muscle

21 January 2018

1 reference

Selective inhibition of 11beta-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice

21 January 2018

1 reference

Anti-diabetic and anti-adipogenic effects of a novel selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor in the diet-induced obese mice

21 January 2018

1 reference

Modulation of glucocorticoid action and the treatment of type-2 diabetes

21 January 2018

1 reference

Effects of the 11 beta-hydroxysteroid dehydrogenase inhibitor carbenoxolone on insulin sensitivity in men with type 2 diabetes.

21 January 2018

1 reference

The 11-beta-hydroxysteroid dehydrogenase type 1 inhibitor INCB13739 improves hyperglycemia in patients with type 2 diabetes inadequately controlled by metformin monotherapy

21 January 2018

1 reference

11beta-Hydroxysteroid dehydrogenase type 1 inhibitors: novel agents for the treatment of metabolic syndrome and obesity-related disorders?

21 January 2018

1 reference

11β-HSD1 inhibitors for the treatment of type 2 diabetes and cardiovascular disease

21 January 2018

1 reference

11β-Hydroxysteroid dehydrogenase blockade prevents age-induced skin structure and function defects

21 January 2018

1 reference

11β-Hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitors still improve metabolic phenotype in male 11β-HSD1 knockout mice suggesting off-target mechanisms

21 January 2018

1 reference

PPARalpha and PPARgamma dual agonists for the treatment of type 2 diabetes and the metabolic syndrome

21 January 2018

1 reference

Muraglitazar, a dual (alpha/gamma) PPAR activator: a randomized, double-blind, placebo-controlled, 24-week monotherapy trial in adult patients with type 2 diabetes

21 January 2018

1 reference

Effect of muraglitazar on death and major adverse cardiovascular events in patients with type 2 diabetes mellitus

21 January 2018

1 reference

Efficacy, safety and tolerability of tesaglitazar when added to the therapeutic regimen of poorly controlled insulin-treated patients with type 2 diabetes

21 January 2018

1 reference

Effect of aleglitazar on cardiovascular outcomes after acute coronary syndrome in patients with type 2 diabetes mellitus: the AleCardio randomized clinical trial

21 January 2018

1 reference

Aerobic exercise and weight loss reduce vascular markers of inflammation and improve insulin sensitivity in obese women

21 January 2018

1 reference

Effects of 1-year orlistat treatment compared to placebo on insulin resistance parameters in patients with type 2 diabetes.

21 January 2018

1 reference

Rimonabant ameliorates insulin resistance via both adiponectin-dependent and adiponectin-independent pathways

21 January 2018

1 reference

Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study

21 January 2018

1 reference

The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1).

21 January 2018

1 reference

Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmö feasibility study

21 January 2018

1 reference

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

21 January 2018

1 reference

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

21 January 2018

1 reference

Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial

21 January 2018

1 reference

Superior weight loss and lower HbA1c 3 years after duodenal switch compared with Roux-en-Y gastric bypass--a randomized controlled trial

21 January 2018

1 reference

Lower ghrelin levels and exaggerated postprandial peptide-YY, glucagon-like peptide-1, and insulin responses, after gastric fundus resection, in patients undergoing Roux-en-Y gastric bypass: a randomized clinical trial.

21 January 2018

1 reference

Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial

21 January 2018

1 reference

Improvement in glucose metabolism after bariatric surgery: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: a prospective randomized trial.

21 January 2018

1 reference

Metabolic risk factors in formerly obese women--effects of a pronounced weight loss by gastric band operation compared with weight loss by diet alone

21 January 2018

1 reference

Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery

21 January 2018

1 reference

Circadian rhythms of GIP and GLP1 in glucose-tolerant and in type 2 diabetic patients after biliopancreatic diversion

21 January 2018

1 reference

Obesity, gut hormones, and bariatric surgery.

21 January 2018

1 reference

Bariatric surgery and taste: novel mechanisms of weight loss.

21 January 2018

1 reference

Mechanisms of weight loss, diabetes control and changes in food choices after gastrointestinal surgery.

21 January 2018

1 reference

FXR is a molecular target for the effects of vertical sleeve gastrectomy

21 January 2018

1 reference

Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications

21 January 2018

1 reference

Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial.

21 January 2018

1 reference

Metabolic effects of bariatric surgery in patients with moderate obesity and type 2 diabetes: analysis of a randomized control trial comparing surgery with intensive medical treatment

21 January 2018

1 reference

Bariatric surgery versus conventional medical therapy for type 2 diabetes

21 January 2018

1 reference

Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes

21 January 2018

1 reference

Effects of Roux-en-Y gastric bypass or diabetes support and education on insulin sensitivity and insulin secretion in morbidly obese patients with type 2 diabetes

21 January 2018

1 reference

Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial

21 January 2018

1 reference

Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects

21 January 2018

1 reference

Improvement in hepatic insulin sensitivity after Roux-en-Y gastric bypass in a rat model of obesity is partially mediated via hypothalamic insulin action

21 January 2018

1 reference

Early enhancements of hepatic and later of peripheral insulin sensitivity combined with increased postprandial insulin secretion contribute to improved glycemic control after Roux-en-Y gastric bypass

21 January 2018

1 reference

Very low-calorie diet mimics the early beneficial effect of Roux-en-Y gastric bypass on insulin sensitivity and β-cell Function in type 2 diabetic patients

21 January 2018

1 reference

Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease

21 January 2018

1 reference

Jejunal nutrient sensing is required for duodenal-jejunal bypass surgery to rapidly lower glucose concentrations in uncontrolled diabetes.

21 January 2018

1 reference

Autonomic nervous system activity in diabetic and healthy obese female subjects and the effect of distinct weight loss strategies.

21 January 2018

1 reference

Bariatric surgery: a systematic review and meta-analysis

21 January 2018

1 reference

New advances in models and strategies for developing anti-obesity drugs

21 January 2018

1 reference

Disruption of the Circadian Clock in Mice Increases Intestinal Permeability and Promotes Alcohol-Induced Hepatic Pathology and Inflammation

21 January 2018

1 reference

Metabolism and circadian rhythms--implications for obesity

21 January 2018

1 reference

Interactions between sleep, circadian function, and glucose metabolism: implications for risk and severity of diabetes

21 January 2018

1 reference

Circadian integration of metabolism and energetics

21 January 2018

1 reference

Circadian control of glucose metabolism.

21 January 2018

1 reference

Adverse metabolic and cardiovascular consequences of circadian misalignment

21 January 2018

1 reference

Circadian misalignment augments markers of insulin resistance and inflammation, independently of sleep loss

21 January 2018

1 reference

Rotating night shift work and risk of type 2 diabetes: two prospective cohort studies in women

21 January 2018

1 reference

Melatonin secretion and the incidence of type 2 diabetes

21 January 2018

1 reference

Long-term longitudinal study on the relationship between alternating shift work and the onset of diabetes mellitus in male Japanese workers.

21 January 2018

1 reference

Associations of chronotype and sleep with cardiovascular diseases and type 2 diabetes.

21 January 2018

1 reference

Chronotype is independently associated with glycemic control in type 2 diabetes

21 January 2018

1 reference

The relationship between breakfast skipping, chronotype, and glycemic control in type 2 diabetes

21 January 2018

1 reference

Circadian rhythms, insulin action, and glucose homeostasis

21 January 2018

1 reference

Impact of sleep debt on metabolic and endocrine function

21 January 2018

1 reference

Role of sleep and sleep loss in hormonal release and metabolism

21 January 2018

1 reference

Short sleep duration measured by wrist actimetry is associated with deteriorated glycemic control in type 1 diabetes

21 January 2018

1 reference

Partial sleep restriction decreases insulin sensitivity in type 1 diabetes

21 January 2018

1 reference

U-shaped association of sleep duration with metabolic syndrome and insulin resistance in patients with type 2 diabetes: the Fukuoka Diabetes Registry.

21 January 2018

1 reference

Effect of sleep deprivation on overall 24 h growth-hormone secretion.

21 January 2018

1 reference

Sleep loss: a novel risk factor for insulin resistance and Type 2 diabetes.

21 January 2018

1 reference

Brief communication: Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite

21 January 2018

1 reference

A single night of sleep deprivation increases ghrelin levels and feelings of hunger in normal-weight healthy men.

21 January 2018

1 reference

Effects of insufficient sleep on blood pressure in hypertensive patients: a 24-h study.

21 January 2018

1 reference

Increasing length of wakefulness and modulation of hypocretin-1 in the wake-consolidated squirrel monkey.

21 January 2018

1 reference

Leptin levels are dependent on sleep duration: relationships with sympathovagal balance, carbohydrate regulation, cortisol, and thyrotropin

21 January 2018

1 reference

Reduced sleep duration or quality: relationships with insulin resistance and type 2 diabetes

21 January 2018

1 reference

Estimating cardiac autonomic activity during sleep: impedance cardiography, spectral analysis, and Poincaré plots.

21 January 2018

1 reference

Neural basis of alertness and cognitive performance impairments during sleepiness. I. Effects of 24 h of sleep deprivation on waking human regional brain activity.

21 January 2018

1 reference

Sleep deprivation effects on the activity of the hypothalamic-pituitary-adrenal and growth axes: potential clinical implications

21 January 2018

1 reference

Adverse effects of modest sleep restriction on sleepiness, performance, and inflammatory cytokines

21 January 2018

1 reference

The effects of extended bedtimes on sleep duration and food desire in overweight young adults: a home-based intervention

21 January 2018

1 reference

Epidemiology of obstructive sleep apnea: a population health perspective

21 January 2018

1 reference

Diagnosis of obstructive sleep apnea in adults

21 January 2018

1 reference

Obstructive sleep apnoea and diabetes: an update

21 January 2018

1 reference

Sleep apnea and glucose metabolism: a long-term follow-up in a community-based sample.

21 January 2018

1 reference

Obstructive sleep apnea in young lean men: impact on insulin sensitivity and secretion

21 January 2018

1 reference

Obstructive sleep apnea syndrome is associated with some components of metabolic syndrome in nonobese adults.

21 January 2018

1 reference

The impact of sleep apnea treatment on carbohydrate metabolism in patients with acromegaly.

21 January 2018

1 reference

Effects of continuous positive airway pressure on glycemic control and insulin resistance in patients with obstructive sleep apnea: a meta-analysis

21 January 2018

1 reference

Meta-analysis: continuous positive airway pressure improves insulin resistance in patients with sleep apnea without diabetes

21 January 2018

1 reference

The impact of effective continuous positive airway pressure on homeostasis model assessment insulin resistance in non-diabetic patients with moderate to severe obstructive sleep apnea

21 January 2018

1 reference

Obstructive sleep apnoea and the risk of type 2 diabetes: a meta-analysis of prospective cohort studies

21 January 2018

1 reference

Sleep apnoea syndrome and 10-year cardiovascular risk in females with type 2 diabetes: relationship with insulin secretion and insulin resistance.

21 January 2018

1 reference

Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetes

21 January 2018

1 reference

The effect of continuous positive airway pressure treatment on insulin sensitivity in patients with obstructive sleep apnoea syndrome and type 2 diabetes

21 January 2018

1 reference

Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea

21 January 2018

1 reference

The effect of continuous positive airway pressure on glucose control in diabetic patients with severe obstructive sleep apnea.

21 January 2018

1 reference

Effect of continuous positive airway pressure therapy on cardiovascular risk factors in patients with type 2 diabetes and obstructive sleep apnea.

21 January 2018

1 reference

Association of obstructive sleep apnea in rapid eye movement sleep with reduced glycemic control in type 2 diabetes: therapeutic implications

21 January 2018

1 reference

Discovery of a Small Molecule Insulin Mimetic with Antidiabetic Activity in Mice

21 January 2018

1 reference

Effects of one year treatment of sibutramine on insulin resistance parameters in type 2 diabetic patients.

21 January 2018

1 reference

3 January 2024

https://opencitations.net/index/api/v1/citations/10.18433/J3388P

Identifiers

DOI

10.1111/DOM.12400

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25308775%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

1 reference